Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.09 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: iguratimod, imalumab | 0.90 |
| trials ClinicalTrials.gov | 11 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 60 Parkinson's papers of 7,833 | 0.46 |
| pathways Reactome | 3 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 2969
Sealed predictions
- MIF in dopamine neurons, braakn/a → n/areceipt 2976
Swarm cases
receipt 2976: MIF in dopamine neurons, braak
- cell type
- MIF is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MIF in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts